167 related articles for article (PubMed ID: 8915769)
1. Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo.
Garcia C; Boyce BF; Gilles J; Dallas M; Qiao M; Mundy GR; Bonewald LF
J Bone Miner Res; 1996 Nov; 11(11):1619-27. PubMed ID: 8915769
[TBL] [Abstract][Full Text] [Related]
2. Effects of synthetic peptido-leukotrienes on bone resorption in vitro.
Garcia C; Qiao M; Chen D; Kirchen M; Gallwitz W; Mundy GR; Bonewald LF
J Bone Miner Res; 1996 Apr; 11(4):521-9. PubMed ID: 8992883
[TBL] [Abstract][Full Text] [Related]
3. 5-Lipoxygenase metabolites inhibit bone formation in vitro.
Traianedes K; Dallas MR; Garrett IR; Mundy GR; Bonewald LF
Endocrinology; 1998 Jul; 139(7):3178-84. PubMed ID: 9645691
[TBL] [Abstract][Full Text] [Related]
4. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of bone resorption by lipoxygenase metabolites of arachidonic acid.
Meghji S; Sandy JR; Scutt AM; Harvey W; Harris M
Prostaglandins; 1988 Aug; 36(2):139-49. PubMed ID: 2847250
[TBL] [Abstract][Full Text] [Related]
6. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase.
Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698
[TBL] [Abstract][Full Text] [Related]
8. An analysis of the relationship between 5-lipoxygenase product generation and the secretion of preformed mediators from mouse bone marrow-derived mast cells.
Razin E; Romeo LC; Krilis S; Liu FT; Lewis RA; Corey EJ; Austen KF
J Immunol; 1984 Aug; 133(2):938-45. PubMed ID: 6330206
[TBL] [Abstract][Full Text] [Related]
9. Osteoclast activation: potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism.
Owens JM; Fuller K; Chambers TJ
J Cell Physiol; 1997 Jul; 172(1):79-86. PubMed ID: 9207928
[TBL] [Abstract][Full Text] [Related]
10. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors.
Amano S; Hanazawa S; Kawata Y; Ohta K; Kitami H; Kitano S
J Bone Miner Res; 1992 Mar; 7(3):321-8. PubMed ID: 1585834
[TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.
McSheehy PM; Chambers TJ
J Clin Invest; 1987 Aug; 80(2):425-9. PubMed ID: 3611354
[TBL] [Abstract][Full Text] [Related]
12. The relevance of leukotrienes for bone resorption induced by mechanical loading.
Moura AP; Taddei SR; Queiroz-Junior CM; Madeira MF; Rodrigues LF; Garlet GP; Souza DG; Machado FS; Andrade I; Teixeira MM; Silva TA
Bone; 2014 Dec; 69():133-8. PubMed ID: 25270168
[TBL] [Abstract][Full Text] [Related]
13. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
Kaji H; Sugimoto T; Kanatani M; Chihara K
J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
[TBL] [Abstract][Full Text] [Related]
14. Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats.
Beaudreuil J; Mbalaviele G; Cohen-Solal M; Morieux C; De Vernejoul MC; Orcel P
J Bone Miner Res; 1995 Jun; 10(6):971-7. PubMed ID: 7572322
[TBL] [Abstract][Full Text] [Related]
15. Avian osteoclast cells are stimulated to resorb calcified matrices by and possess receptors for leukotriene B4.
Flynn MA; Qiao M; Garcia C; Dallas M; Bonewald LF
Calcif Tissue Int; 1999 Feb; 64(2):154-9. PubMed ID: 9914324
[TBL] [Abstract][Full Text] [Related]
16. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells.
Mencia-Huerta JM; Razin E; Ringel EW; Corey EJ; Hoover D; Austen KF; Lewis RA
J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts.
Yates AJ; Oreffo RO; Mayor K; Mundy GR
J Bone Miner Res; 1991 May; 6(5):473-8. PubMed ID: 2068953
[TBL] [Abstract][Full Text] [Related]
18. The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro.
Flanagan AM; Stow MD; Kendall N; Brace W
Int J Exp Pathol; 1995 Feb; 76(1):37-42. PubMed ID: 7734338
[TBL] [Abstract][Full Text] [Related]
19. Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents.
Kneissel M; Studer A; Cortesi R; Susa M
Bone; 2005 Feb; 36(2):202-14. PubMed ID: 15780946
[TBL] [Abstract][Full Text] [Related]
20. Mouse bone marrow-derived mast cells cocultured with fibroblasts. Morphology and stimulation-induced release of histamine, leukotriene B4, leukotriene C4, and prostaglandin D2.
Levi-Schaffer F; Dayton ET; Austen KF; Hein A; Caulfield JP; Gravallese PM; Liu FT; Stevens RL
J Immunol; 1987 Nov; 139(10):3431-41. PubMed ID: 2445814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
